Vynnycky, E. & Fine, P. E. Lifetime risks, incubation period, and serial interval of tuberculosis. Am. J. Epidemiol. 152, 247–263 (2000).
World Health Organization. Global tuberculosis report 2024. (2024). https://www.who.int/publications/i/item/9789240101531
Oliveira, G. S. et al. Antimicrobial peptides as potential anti-tubercular leads: a concise review. Pharmaceuticals (Basel). 14, 323 (2021).
Dookie, N. et al. Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. J. Antimicrob. Chemother. 73, 1138–1151 (2028).
Abrahams, K. A. et al. DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and Delamanid. Nat. Commun. 14, 3828 (2023).
Nguyen, T. V. A. et al. Pretomanid resistance: an update on emergence, mechanisms and relevance for clinical practice. Int. J. Antimicrob. Agents. 62, 106953 (2023).
Moretta, A. et al. Antimicrobial peptides: a new hope in biomedical and pharmaceutical fields. Front. Cell. Infect. Microbiol. 11, 668632 (2021).
Intorasoot, S. et al. In vitro antimycobacterial activity of human lactoferrin-derived peptide, D-hLF 1–11, against susceptible and drug-resistant Mycobacterium tuberculosis and its synergistic effect with rifampicin. Antibiot. (Basel). 11, 1785 (2022).
Silva, T. et al. Lactoferricin peptides increase macrophages’ capacity to kill Mycobacterium avium. mSphere 2, e00301–e00317 (2017).
Jacobo-Delgado, Y. M. et al. Mycobacterium tuberculosis cell-wall and antimicrobial peptides: a mission impossible? Front. Immunol. 14, 1194923 (2023).
Moghassemi, S. & Hadjizadeh, A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J. Control Release. 185, 22–36 (2014).
PaweLczyk, J. & Kremer, L. The molecular genetics of mycolic acid biosynthesis. Microbiol. Spectr. 2, MGM2-0003-2013 (2014).
Sangboonruang, S. et al. Nano-delivery system of ethanolic extract of propolis targeting Mycobacterium tuberculosis via aptamer-modified-niosomes. Nanomaterials (Basel). 13, 269 (2023).
Sangboonruang, S. et al. Potentiality of melittin-loaded Niosomal vesicles against vancomycin-intermediate Staphylococcus aureus and Staphylococcal skin infection. Int. J. Nanomed. 16, 7639–7661 (2021).
Sadeghi, S. et al. Synergistic anti-Staphylococcal activity of Niosomal Recombinant lysostaphin-LL-37. Int. J. Nanomed. 14, 9777–9792 (2019).
Sangboonruang, S. et al. Multifunctional poloxamer-based thermo-responsive hydrogel loaded with human lactoferricin niosomes: in vitro study on anti-bacterial activity, accelerate wound healing, and anti-inflammation. Int. J. Pharm. X. 8, 100291 (2024).
Hafez, I. M. & Cullis, P. R. Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior. Biochim. Biophys. Acta. 1463, 107–114 (2000).
Ag Seleci, D. et al. Rapid microfluidic Preparation of niosomes for targeted drug delivery. Int. J. Mol. Sci. 20, 4696 (2019).
Li, X. et al. Microfluidics-assembled nanovesicles for nucleic acid delivery. Acc. Chem. Res. 18, 570–582 (2025).
Ali, M. S. et al. Microfluidics for development of lipid nanoparticles: paving the way for nucleic acids to the clinic. ACS Appl. Bio Mater. 6, 3566–3576 (2023).
Mishra, V. et al. Quality by design (QbD) approaches in current pharmaceutical set-up. Expert Opin. Drug Deliv. 15, 737–758 (2018).
Aziz, D. E., Abdelbary, A. A. & Elassasy, A. I. Implementing central composite design for developing transdermal diacerein-loaded niosomes: ex vivo permeation and in vivo deposition. Curr. Drug Deliv. 15, 1330–1342 (2018).
Poomanee, W. et al. Optimization of Mangifera indica L. kernel extract-loaded nanoemulsions via response surface methodology, characterization, stability, and skin permeation for anti-acne cosmeceutical application. Pharmaceutics 12, 454 (2020).
Gruden, S. Poklar ulrih, N. Diverse mechanisms of antimicrobial activities of lactoferrins, lactoferricins, and other lactoferrin-derived peptides. Int. J. Mol. Sci. 22, 11264 (2021).
Ohradanova-Repic, A. et al. Time to kill and time to heal: the multifaceted role of lactoferrin and lactoferricin in host defense. Pharmaceutics 15, 1056 (2023).
Obeid, M. A. et al. Niosome-encapsulated balanocarpol: compound isolation, characterisation, and cytotoxicity evaluation against human breast and ovarian cancer cell lines. Nanotechnology 31, 195101 (2020).
Dabbagh, M. F. et al. Delivery of melittin-loaded niosomes for breast cancer treatment: an in vitro and in vivo evaluation of anti-cancer effect. Cancer Nano. 12, 14 (2021).
Yalcin, T. E. & Yetgin, C. Influence of formulation composition on the characteristic properties of 5-fluorouracil-loaded liposomes. Turk. J. Pharm. Sci. 21, 551–556 (2025).
Monteiro, L. O. F. et al. Paclitaxel-loaded pH-sensitive liposome: new insights on structural and physicochemical characterization. Langmuir 34, 5728–5737 (2018).
Parbhoo, T., Mouton, J. M. & Sampson, S. L. Phenotypic adaptation of Mycobacterium tuberculosis to host-associated stressors that induce persister formation. Front. Cell. Infect. Microbiol. 12, 956607 (2022).
Rascon-Cruz, Q. et al. Lactoferrin: a glycoprotein involved in immunomodulation, anticancer, and antimicrobial processes. Molecules 26, 205 (2021).
Kim, E. Y. & Kim, B. C. Lipopolysaccharide inhibits transforming growth factor-beta1-stimulated Smad6 expression by inducing phosphorylation of the linker region of Smad3 through a TLR4-IRAK1-ERK1/2 pathway. FEBS Lett. 585, 779–785 (2011).
Yami, H. A. et al. The Immunomodulatory effects of lactoferrin and its derived peptides on NF-kappaB signaling pathway: a systematic review and meta-analysis. Immun. Inflamm. Dis. 11, e972 (2023).
Penuelas-Urquides, K. et al. Measuring of Mycobacterium tuberculosis growth. A correlation of the optical measurements with colony forming units. Braz J. Microbiol. 44, 287–289 (2013).
Szklarczyk, D. et al. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 44, D380–D384 (2016).
Kareem, S. et al. Complement: functions, location and implications. Immunology 170, 180–192 (2023).
Fattahi, F. et al. Requirement of complement c6 for intact innate immune responses in mice. J. Immunol. 205, 251–260 (2020).
Kruzel, M. L., Zimecki, M. & Actor, J. K. Lactoferrin in a context of inflammation-induced pathology. Front. Immunol. 8, 1438 (2017).
Spadaro, O. et al. Growth hormone receptor deficiency protects against age-related nlrp3 inflammasome activation and immune senescence. Cell. Rep. 14, 1571–1580 (2016).
Girnita, L. et al. Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation. Cell. Mol. Life Sci. 71, 2403–2427 (2014).
Yang, W. L. et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325, 1134–1138 (2009).
Ma, Q. et al. TRAF6 triggers Mycobacterium-infected host autophagy through Rab7 ubiquitination. Cell. Death Discov. 9, 427 (2023).
Miyazawa, K. & Miyazono, K. Regulation of TGF-beta family signaling by inhibitory Smads. Cold Spring Harb Perspect. Biol. 9, a022095 (2017).
Bacchelli, C. et al. Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency. J. Allergy Clin. Immunol. 139, 634–642 (2017).
Whittaker, G. C. et al. The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells. J. Biol. Chem. 285, 2976–2985 (2010).
Bradshaw, W. J. et al. Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2. Structure 32, 453–466 (2024).
He, J. et al. Association of PI3K/AKT/mTOR pathway autophagy-related gene polymorphisms with pulmonary tuberculosis susceptibility in a Chinese population. Rev. Soc. Bras. Med. Trop. 56, e01042023 (2023).
Wang, Y. et al. LRCH1 suppresses migration of CD4(+) T cells and refers to disease activity in ulcerative colitis. Int. J. Med. Sci. 17, 599–608 (2020).
Shen, L., Li, Y. & Zhao, H. Fibroblast growth factor signaling in macrophage polarization: impact on health and diseases. Front. Immunol. 15, 1390453 (2024).
Liu, C., Liu, C. & Fu, R. Research progress on the role of PKM2 in the immune response. Front. Immunol. 13, 936967 (2022).
Kim, M. H. et al. Association of genetic variants of oxidative stress responsive kinase 1 (OXSR1) with asthma exacerbations in non-smoking asthmatics. BMC Pulm Med. 22, 3 (2022).
Hortle, E. et al. OXSR1 inhibits inflammasome activation by limiting potassium efflux during mycobacterial infection. Life Sci. Alliance. 5, e202201476 (2022).
Peng, D. et al. A novel function of F-BOX protein FBXO17 in negative regulation of type I IFN signaling by recruiting PP2A for IFN regulatory factor 3 deactivation. J. Immunol. 198, 808–819 (2017).
Li, P. et al. AMP deaminase 3 plays a critical role in remote reperfusion lung injury. Biochem. Biophys. Res. Commun. 434, 131–136 (2013).
Ju, J. et al. Phosphorylation of p50 NF-kappaB at a single Serine residue by DNA-dependent protein kinase is critical for VCAM-1 expression upon TNF treatment. J. Biol. Chem. 285, 41152–41160 (2010).
Ghonim, M. A. et al. Unconventional activation of PRKDC by TNF-alpha: Deciphering its crucial role in Th1-mediated inflammation beyond DNA repair as part of the DNA-PK complex. J. Inflamm. (Lond). 21, 14 (2024).
Lee, Y. R. et al. DNA-dependent protein kinase catalytic subunit (dna-pkcs): beyond the Dna double-strand break repair. Mol. Cells. 46, 200–205 (2023).
Okigaki, M. et al. Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proc. Natl. Acad. Sci. USA. 100, 10740–10745 (2003).
Wang, D. et al. SIRPalpha maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis. EBioMedicine 85, 104278 (2022).
Chen, Y. et al. Mycobacterium tuberculosis/mycobacterium Bovis triggered different variations in lipid composition of bovine alveolar macrophages. Sci. Rep. 12, 13115 (2022).
Lowry, O. H. et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951).
Tyanova, S. et al. The perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods. 13, 731–740 (2016).
Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301–2319 (2016).
Pang, Z. et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 52, W398–W406 (2024).
Mi, H. et al. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 47, D419–D426 (2019).
Bardou, P. et al. Jvenn: an interactive Venn diagram viewer. BMC Bioinf. 15, 293 (2014).
von Mering, C. et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 33, D433–D437 (2005).
